U.S. To Review Chiron's Hepatitis C Patent Deal
The CDC's inquiry comes amid complaints that Chiron's control over the discovery has delayed research into treatments and vaccines, the Kansas Star reported.
“CDC will continue to review this matter with a number of partners involved in Hepatitis prevention,” the agency told the Kansas Star.
The hepatitis C virus (HCV) is transmitted...
To view the full article, register now.